We will study the genetic basis for the coordinate regulation of bacterial virulence determinants utilizing three experimental organisms-Vibrio cholerae, Bordetella pertussia and Escherchia coli. Our goal is to define the molecular mechanism by which groups of virulence genes in each organism are concomitantly expressed or repressed. The experimental approach to this goal will be similar for each of the genetic systems examined and will include the following steps: 1. Analysis of nutritional and physical parameters that regulate virulence; 2. Isolation of TnphoA gene fusions that are regulated by these parameters; 3. Confirmation that the expected virulence regulatory gene controls the expression of these TnphoA gene fusions; 4. Identification of the promoter and control sites for selected TnphoA fusions by standard methods (i.e., DNA sequencing, S1 and primer extention mRNA mapping, deletion, chemical, and oligonucleotide-directed mutagenesis, and protein-DNA binding studies). For V. cholerae we will expand our analysis of the toxR coordinate regulatory system to include other possible ToxR-regulated virulence properties (i.e., expression of pili, OMPs, neuraminadase, protease, hemolysis, and motility). In B. pertussis we will continue our analysis of vir positive and negative coordinate regulation to include promoter structure and genetic analysis of the modulation response. For V. cholerae and E. coli we will study iron-regulatory responses focusing on the genes for Shiga- like toxin type 1 (sltAB) as well as other virulence factors (e.g., hemolysin, invasive properties, and adherence factors) potentially controlled by the iron-responsive fur gene products of each organism. Where possible, we will apply data we collect to the development and improvement of cholera and pertussis vaccines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI026289-03
Application #
3140038
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1988-05-01
Project End
1993-04-30
Budget Start
1990-05-01
Budget End
1991-04-30
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Skurnik, David; Clermont, Olivier; Guillard, Thomas et al. (2016) Emergence of Antimicrobial-Resistant Escherichia coli of Animal Origin Spreading in Humans. Mol Biol Evol 33:898-914
Roux, Damien; Danilchanka, Olga; Guillard, Thomas et al. (2015) Fitness cost of antibiotic susceptibility during bacterial infection. Sci Transl Med 7:297ra114
Fu, Yang; Mekalanos, John J (2014) Infant Rabbit Colonization Competition Assays. Bio Protoc 4:
Ho, Brian T; Dong, Tao G; Mekalanos, John J (2014) A view to a kill: the bacterial type VI secretion system. Cell Host Microbe 15:9-21
Basler, Marek; Ho, Brian T; Mekalanos, John J (2013) Tit-for-tat: type VI secretion system counterattack during bacterial cell-cell interactions. Cell 152:884-94
Ho, Brian T; Basler, Marek; Mekalanos, John J (2013) Type 6 secretion system-mediated immunity to type 4 secretion system-mediated gene transfer. Science 342:250-3
Fu, Yang; Waldor, Matthew K; Mekalanos, John J (2013) Tn-Seq analysis of Vibrio cholerae intestinal colonization reveals a role for T6SS-mediated antibacterial activity in the host. Cell Host Microbe 14:652-63
Skurnik, David; Roux, Damien; Cattoir, Vincent et al. (2013) Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing. Proc Natl Acad Sci U S A 110:20747-52
Danilchanka, Olga; Mekalanos, John J (2013) Cyclic dinucleotides and the innate immune response. Cell 154:962-970
Shneider, Mikhail M; Buth, Sergey A; Ho, Brian T et al. (2013) PAAR-repeat proteins sharpen and diversify the type VI secretion system spike. Nature 500:350-353

Showing the most recent 10 out of 81 publications